This analysis examines the historical and forecast performance for GSK in the prescription pharmaceutical sector.

Dallas, TX -- (SBWire) -- 08/11/2010 -- Dallas, TX: ReportsandReports announce it will carry GlaxoSmithKline plc: PharmaVitae Profile Market Research Report in its Store.

Browse complete Report on: http://www.reportsandreports.com/market-reports/glaxosmithkline-plc-pharmavitae-profile/

This analysis examines the historical and forecast performance for GSK in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information.

Reasons to Purchase

• Benchmark GlaxoSmithKline's performance against key rivals in the prescription pharmaceutical sector
• Assess the threat posed by generic competition to GlaxoSmithKline's core prescription pharmaceutical business
• Analyze the future strategic direction of GSK, namely an enhanced vaccine offering, geographic diversification and increased biologics presence

Table Of contents

ABOUT DATAMONITOR HEALTHCARE 2
About the PharmaVitae team 2

Chapter 1 About this profile 3
PharmaVitae Explorer database 3
Chapter structure 3
Executive summary 3
Quarterly news update 3
Company introduction 3
Company sales 4
Company financials 4
Key products and competitors 4
Data sourcing 4
Sales data 4
Analyst consensus 4

Chapter 2 Executive summary 5
Key findings 5
Prescription pharmaceutical sales and growth rate performance, 2002-14 6
Financial performance, 2002-14 7
GlaxoSmithKline: PharmaVitae forecasts at a glance 8
Strategic insight 9
Introduction 9
Analysis of sales performance 2002-08 9
Analysis of sales performance 2008-14 10
Outlook 14
SWOT analysis 16
Strengths 17
Weaknesses 18
Opportunities 18
Threats 20
Table of Contents 22
Table of figures 24

Chapter 3 Quarterly news update 25
Product developments 25
Deals and alliances 27
Product deals 27
Technology deals 32
M&A activity 33
Company announcements 33
Future product milestones 35

Chapter 4 Company introduction 38
Key findings 38
Background 39
M&A history 39
Glaxo and Wellcome 39
Glaxo Wellcome 39
Smith Kline and Beecham 39
SmithKline Beecham 40
Key historical drug launches by component GSK companies 41
M&A strategy 41
R&D overview 44

Chapter 5 Company sales 46
Key findings 46
Prescription pharmaceutical sales and growth rate analysis, 2002-14 47
Product analysis 49
Product analysis, 2002-08 50
Product analysis, 2008-14 53
Therapy area analysis 56
Geographic analysis 59
Launch/core/expiry analysis 61
Explanation of launch/core/expiry analysis 61
Launch analysis, 2008-14 62
Core analysis, 2008-14 65
Expiry analysis, 2008-14 66
Launch/core/expiry configuration, 2008-14 68
Molecule type analysis 69
Externalization analysis 73

Chapter 6 Company financials 76
Key findings 76
Reconciliation between PharmaVitae-formatted prescription pharma sales and company-reported total sales, 2002-08 77
Operating costs and profit analysis 78
Operating costs and profit analysis, 2002-08 79
Operating cost ratio and profit margin analysis, 2002-08 80
Operating cost ratio and profit margin analysis, 2008-14 81
Operating costs and profit analysis, 2008-14 82

Chapter 7 Key products and competitors 83
Overview 83
Respiratory 84
Seretide/Advair 84
Overview 84
Sales forecast 85
Beyond Advair 87
Overview 87
Sales forecast 88
Infectious diseases 89
Cervarix 89
Overview 89
Sales forecast 90
Valtrex 93
Overview 93
Sales forecast 94
Oncology 95
Tykerb/Tyverb 95
Overview 95
Sales forecast 96
Genitourinary 98
Duodart 98
Overview 98
Sales forecast 99
Central Nervous system 100
Almorexant 100
Overview 100
Sales forecast 101
Lamictal 102
Overview 102
Sales forecast 103
Imigran/Imitrex 105
Overview 105
Sales forecast 106
Endocrinology 108
Avandia 108
Overview 108
Sales forecast 109

Chapter 8 Appendix 112
R&D pipeline 112
Abbreviations 115
Exchange rates 116
About Datamonitor 117
About Datamonitor Healthcare 117
Datamonitor consulting 117
Disclaimer 119

Browse complete Report on: http://www.reportsandreports.com/market-reports/glaxosmithkline-plc-pharmavitae-profile/

Browse all Healthcare Market Research Reports on:
http://www.reportsandreports.com/market-research/healthcare/

Browse all Datamonitor Market Research Reports on:
http://www.reportsandreports.com/Publishers/datamonitor/

Browse all Latest Report on:
http://www.reportsandreports.com/LatestReport.aspx

Related Reports:

GlaxoSmithKline plc Market Share Analysis
http://www.reportsandreports.com/market-reports/glaxosmithkline-plc-market-share-analysis/

GlaxoSmithKline plc-Company Report
http://www.reportsandreports.com/market-reports/glaxosmithkline-plc-company-report/

GlaxoSmithKline Plc - SWOT Analysis
http://www.reportsandreports.com/market-reports/glaxosmithkline-plc-swot-analysis/

About Us:
Reports and Reports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.

Contact:
Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004
Website: http://www.reportsandreports.com/
Blog: http://reportsnreports.wordpress.com/
Blog: http://reportsandreports.blogspot.com/